CVIR Endovascular

Table 4 Outcome parameters initially and at follow up

From: Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization

		Initial	Follow-up	P-value*
Number	n	69	66
Volume; ml	Mean ± SD	105 ± 60	79 ± 43	< 0.01
IPP; mm	Mean ± SD	13 ± 7	10 ± 9	< 0.01
PUA; degree	Mean ± SD	69 ± 15	60 ± 15	< 0.01
Medication number of drugs	median (IQR))	2 (0 – 3)	0 (0 – 3)	< 0.01
IPSS	median (IQR)	20 (15 – 24)	8 (4 – 13)	< 0.01
Bladder catheter		20	2
Qmax; ml/s	Mean ± SD	11 ± 6	15 ± 9	0.02

IPP Intraprostatic protrusion, PUA Prostatic urethral angle, IPSS International prostatic symptoms score, IQR Interquartile range
^*Wilcoxon-rank-sum-test was used to check for statistical significance

Back to article page